Game On: Topokine Initiates Late-Stage Trial of XAF5 Ointment for Reining in Undereye Bags
Topokine Therapeutics initiated a Phase 2b/3 trial for XAF5 Ointment for the reduction of undereye bags.
Topokine Therapeutics initiated a Phase 2b/3 trial for XAF5 Ointment for the reduction of undereye bags.
The American Academy of Facial Plastic and Reconstructive Surgery is highlighting how energy-based devices are reshaping non-surgical facial rejuvenation in 2025.
The device features a mode allowing for the simultaneous application of 1927nm Thulium and 1550nm Erbium wavelengths to treat a range of skin conditions.
Preservé offers plastic surgeons a minimally invasive approach to breast augmentation with enhanced tissue preservation.
The investment will help scale the company’s 2910 nm fiber laser platforms, designed for use across all skin types.
Dynavisc adhesion barrier gel is designed to reduce the formation of adhesions following tendon and peripheral nerve related surgical procedures.